TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
8/2/24 17:01 | 8/1/24 | PTN | Palatin Technologies Inc | NJ | Health | Drug | Pharmaceutical Preparations | Wills Stephen T | NJ | O | EVP,CFO, | S | -8 | 1.66 | 0 | -5 | -2 | 235 | D | ||||||||||||||
12/8/23 17:30 | 12/6/23 | PTN | Palatin Technologies Inc | NJ | Health | Drug | Pharmaceutical Preparations | Wills Stephen T | NJ | O | EVP,CFO, | S | -13 | 2.51 | 0 | -5 | -2 | 328 | D | ||||||||||||||
12/28/22 10:29 | 12/27/22 | PTN | Palatin Technologies Inc | NJ | Health | Drug | Pharmaceutical Preparations | Wills Stephen T | NJ | O | EVP,CFO, | P.a | 22 | 2.22 | 0 | 10 | 4 | 267 | D | ||||||||||||||
10/4/22 16:43 | 9/30/22 | GMDA | Gamida Cell Ltd. | L3 | Health | BioPrd | Biological Products, (No Diag | Wills Stephen T | MA | D | P | 15 | 1.55 | 0 | 10 | 484 | 12 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |